TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-9.39%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$982M
AUM Growth
+$982M
(+2.2%)
Cap. Flow
+$152M
Cap. Flow
% of AUM
15.44%
Top 10 Holdings %
Top 10 Hldgs %
37.6%
Holding
143
New
43
Increased
39
Reduced
6
Closed
15
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$28.1M |
| 2 |
ANI Pharmaceuticals
ANIP
|
$19.1M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$15.9M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$14.9M |
| 5 |
CRISPR Therapeutics
CRSP
|
$10.8M |
Top Sells
| 1 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$24.5M |
| 2 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$14.5M |
| 3 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.44M |
| 4 |
Intellia Therapeutics
NTLA
|
$5.5M |
| 5 |
BLUE
bluebird bio
BLUE
|
$3.2M |
Sector Composition
| 1 | Healthcare | 95.92% |
| 2 | Technology | 1.53% |
| 3 | Real Estate | 0.71% |
| 4 | Communication Services | 0.66% |
| 5 | Financials | 0.14% |
